Community actions
-
Holding
-
Recently bought
-
Recently sold
Lexicon Pharmaceuticals, Inc. news
-
Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
-
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
-
Lexicon Pharmaceuticals Inc (LXRX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
-
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
-
Lexicon Pharmaceuticals Reports Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic ...
-
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
-
Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals
-
All You Need to Know About Lexicon (LXRX) Rating Upgrade to Buy
-
Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Recent Motivations
-
Lou Könik
Bought35 shares of
-
💡 Litar på magkänslan
-
-
F1dd092
Sold20 shares of-
💵 Frigör lite SprinkleBucks
-
-
F1dd092Sold20 shares of
-
💵 Frigör lite SprinkleBucks
-
-
Thomas Lindow
Bought49 shares of-
📊 Jag tycker den är undervärderad just nu
-
-
F1dd092Bought40 shares of
-
💡 Litar på magkänslan
-